<VariationArchive VariationID="631984" VariationName="NM_006502.3(POLH):c.149dup (p.Ser51fs)" VariationType="Duplication" Accession="VCV000631984" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2019-05-27" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="620232" VariationID="631984">
      <GeneList>
        <Gene Symbol="POLH" FullName="DNA polymerase eta" GeneID="5429" HGNC_ID="HGNC:9181" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="43576185" stop="43620523" display_start="43576185" display_stop="43620523" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="43543877" stop="43588259" display_start="43543877" display_stop="43588259" Strand="+" />
          </Location>
          <OMIM>603968</OMIM>
        </Gene>
        <Gene Symbol="POLR1C" FullName="RNA polymerase I and III subunit C" GeneID="9533" HGNC_ID="HGNC:20194" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>6p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="43517089" stop="44461400" display_start="43517089" display_stop="44461400" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="43484776" stop="43489250" display_start="43484776" display_stop="43489250" Strand="+" />
          </Location>
          <OMIM>610060</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006502.3(POLH):c.149dup (p.Ser51fs)</Name>
      <CanonicalSPDI>NC_000006.12:43583017:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6p21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="43583017" stop="43583018" display_start="43583017" display_stop="43583018" variantLength="1" positionVCF="43583017" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="43550754" stop="43550755" display_start="43550754" display_stop="43550755" variantLength="1" positionVCF="43550754" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>S51fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006502.2" sequenceAccession="NM_006502" sequenceVersion="2" change="c.149dupT">
            <Expression>NM_006502.2:c.149dupT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.43550755dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.43550755dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.43583018dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.43583018dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009252.1" sequenceAccession="NG_009252" sequenceVersion="1" change="g.11878dup">
            <Expression>NG_009252.1:g.11878dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_028283.4" sequenceAccession="NG_028283" sequenceVersion="4" change="g.70931dup">
            <Expression>NG_028283.4:g.70931dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001291969.2" sequenceAccession="NM_001291969" sequenceVersion="2" change="c.-6dup">
            <Expression>NM_001291969.2:c.-6dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001291970.2" sequenceAccession="NM_001291970" sequenceVersion="2" change="c.149dup">
            <Expression>NM_001291970.2:c.149dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001278899.1" sequenceAccession="NP_001278899" sequenceVersion="1" change="p.Ser51fs">
            <Expression>NP_001278899.1:p.Ser51fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006502.3" sequenceAccession="NM_006502" sequenceVersion="3" change="c.149dup" MANESelect="true">
            <Expression>NM_006502.3:c.149dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006493.1" sequenceAccession="NP_006493" sequenceVersion="1" change="p.Ser51fs">
            <Expression>NP_006493.1:p.Ser51fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318876.2" sequenceAccession="NM_001318876" sequenceVersion="2" change="c.945+53747dup">
            <Expression>NM_001318876.2:c.945+53747dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_470" sequenceAccession="LRG_470">
            <Expression>LRG_470:g.11878dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_470t1" sequenceAccession="LRG_470t1">
            <Expression>LRG_470t1:c.149dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_470p1" sequenceAccession="LRG_470p1" change="p.Ser51Glufs">
            <Expression>LRG_470p1:p.Ser51Glufs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="752080248" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00003" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006502.3(POLH):c.149dup (p.Ser51fs) AND Xeroderma pigmentosum variant type" Accession="RCV000778796" Version="14">
        <ClassifiedConditionList TraitSetID="1635">
          <ClassifiedCondition DB="MedGen" ID="C1848410">Xeroderma pigmentosum variant type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-09-18" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006502.3(POLH):c.149dup (p.Ser51fs) AND not provided" Accession="RCV003558583" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-18" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-05-27" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11773631</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18368133</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24130121</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25256075</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26884178</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-11">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1635" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5132" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosum with normal DNA repair rates</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Photosensitivity with defective DNA synthesis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum variant type</ElementValue>
                <XRef ID="MONDO:0010214" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XPV</ElementValue>
                <XRef Type="MIM" ID="278750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5630" />
                <XRef ID="5630" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="90342" DB="Orphanet" />
              <XRef ID="C1848410" DB="MedGen" />
              <XRef ID="MONDO:0010214" DB="MONDO" />
              <XRef Type="MIM" ID="278750" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1790238" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="1371869" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915167" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26884178</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18368133</ID>
          </Citation>
          <Comment>The POLH c.149dupT (p.Ser51GlufsTer3) variant results in a frameshift and is predicted to result in premature termination of the protein, and has been reported in two Caucasian individuals with xeroderma pigmentosum (XP) (Inui et al. 2008; Fassihi et al. 2016). One of these individuals, who was homozygous, was diagnosed at the age of 16 with squamous cell carcinoma and developed five non-melanoma skin cancers by the age of 20. He did not present with neurological symptoms. The second individual, who was compound heterozygous for the p.Ser51GlufsTer3 variant and a missense variant, developed multiple cutaneous basal cell carcinomas and melanomas by the age of 31. Her father was heterozygous for the variant. Control data are unavailable for this variant, which is reported at a frequency of 0.000046 in the European (non-Finnish) population of the Exome Aggregation Consortium. IP-Western blotting of whole-cell extracts from the compound heterozygous patient's fibroblasts revealed only trace levels of polÎ· protein (Inui et al. 2008). Fibroblasts from both individuals did not display reduced levels of post-UV nucleotide excision repair, consistent with the variant form of XP (Inui et al. 2008; Fassihi et al. 2016). Based on the evidence and the potential impact of frameshift variants, the p.Ser51GlufsTer3 variant is classified as likely pathogenic for xeroderma pigmentosum. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="GT" referenceAllele="G" start="43550754" stop="43550754" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006502.2:c.149dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="278750" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7979439" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4862097|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004293643" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11773631</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24130121</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25256075</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18368133</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser51Glufs*3) in the POLH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POLH are known to be pathogenic (PMID: 11773631, 24130121, 25256075). This variant is present in population databases (rs752080248, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with xeroderma pigmentosum (PMID: 18368133). ClinVar contains an entry for this variant (Variation ID: 631984). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.43550754_43550755insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7979439" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1790238" TraitType="Disease" MappingType="XRef" MappingValue="278750" MappingRef="OMIM">
        <MedGen CUI="C1848410" Name="Xeroderma pigmentosum variant type" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

